Aldesleukin Completed Phase 3 Trials for Graft Versus Host Disease (GVHD) / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00003414Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease